Artificial Intelligence Analysis of Standard 12-Lead Electrocardiograms for Screening of Symptomatic Diabetic Peripheral Neuropathy.

Authors

Paweł Ignacy, Hanadi Aldosari, Krzysztof Irlik, Martyna Gut-Misiaga, Aleksandra Gil, Hanna Kwiendacz, Janusz Gumprecht, Gregory Y H Lip, Uazman Alam, Katarzyna Nabrdalik

Published in

Diabetes, obesity & metabolism. Aug 19, 2026. Epub Aug 19, 2026.

Abstract

To investigate whether artificial intelligence (AI) models trained on standard 12-lead electrocardiograms (ECG) can identify symptom-defined diabetic peripheral neuropathy (DPN) as assessed by the Michigan Neuropathy Screening Instrument Questionnaire (MNSI-Q).
This was an observational study of people with diabetes enrolled in the Silesia-Diabetes Heart Project. DPN was assessed using the MNSI-Q. We used an original questionnaire cut-off score of ≥ 7 and revised cut-off score of ≥ 4 to diagnose DPN and classified DPN as highly symptomatic and moderately symptomatic accordingly. Feature extraction from 10-s raw ECG recordings utilised algorithms to identify recurring signal segments (motifs) and anomalies (discords). These features were used to train XGBoost, Support Vector Machine (SVM) and Ridge classifiers to differentiate between DPN-positive and DPN-negative people.
A total of 640 participants (mean age 54 ± 17; 52% female) were included. Of these, 95 (15%) had highly symptomatic DPN (MNSI-Q ≥ 7) and 281 (44%) had moderately symptomatic DPN (MNSI-Q ≥ 4). For the highly symptomatic DPN, the XGBoost classifier utilizing a combination of motifs and discords demonstrated the highest performance, achieving an area under the receiver-operating characteristic curve (AUC) of 0.89 (95% CI 0.88-0.91), an accuracy of 88.5% and a sensitivity of 93.4%. The model showed substantially lower predictive capability when tested against the broader screening threshold of MNSI ≥ 4 (AUC 0.64).
AI analysis of the standard ECG demonstrated a strong association with the presence of symptom-defined peripheral neuropathy but lacked sensitivity for milder presentation. With further validation, this method could serve as an accessible, supplementary screening aid to help identify high-risk patients during routine cardiovascular assessment.

PMID:
42618536
Bibliographic data and abstract were imported from PubMed on 20 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.